DJWAN SCOTT: Open Payments
NPI 1821336652 · HAVERHILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 10 payments from 8 companies in 2025. Trend: 2023 $1,099 · 2024 $743 · 2025 $1,339
Food & beverage: $899Speaker / faculty: $440
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $440 |
| ABBVIE INC. | 2 | $199 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $198 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| ACADIA Pharmaceuticals Inc | 1 | $101 |
| E.R. Squibb & Sons, L.L.C. | 1 | $98 |
| SCPHARMACEUTICALS INC. | 1 | $35 |
Products named: Korlym, REXULTI, AMVUTTRA, AIRSUPRA, SKYRIZI, NUPLAZID, COBENFY, VRAYLAR.
Industry payments across MA — which companies pay providers there.
